RUNX3 Inhibits the Invasion and Metastasis of Human Colon Cancer HT-29 Cells by Upregulating MMP-2/9.

Conclusion: RUNX3 can inhibit the invasion and metastasis of human colon cancer HT-29 cells, and the mechanism may be related to decreased expression of MMP-2 and MMP-9. PMID: 32184893 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32184893?dopt=Abstract

Source: Evidence-based Complementary and Alternative Medicine - March 20, 2020 Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research